Benzinga | Oct 29, 2020 08:17AM EDT

Pacira BioSciences Q3 EPS $0.68 Beats $0.61 Estimate, Sales $117.48M Beat $115.15M Estimate

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.61 by 11.48 percent. This is a 41.67 percent increase over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $117.48 million which beat the analyst consensus estimate of $115.15 million by 2.03 percent. This is a 12.23 percent increase over sales of $104.69 million the same period last year.